NCT02106234View on ClinicalTrials.gov

A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective?

NACompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2017

Conditions
Contrast Induced NephropathyAcute Kidney Injury
Interventions
OTHER

No prophylactic iv hydration

Control group: Patients having been referred for an elective procedure involving intravascular iodinated contrast material administration and for intravenous prophylactic hydration according to current guidelines (but only those patients with an eGFR ≥30ml/min/1.73m2) will NOT receive the standard intravenous prophylactic hydration treatment with normal saline prescribed.

Trial Locations (1)

6202AZ

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT02106234 - A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective? | Biotech Hunter | Biotech Hunter